Morgan Stanley Aziyo Biologics, Inc. Transaction History

Morgan Stanley

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$1.19 - $4.96 $2,025 - $8,441	-1,702 Reduced 57.46%	1,260 $1,000
Q4 2022 Feb 14, 2023	SELL	$3.48 - $8.94 $2,415 - $6,204	-694 Reduced 18.98%	2,962 $12,000
Q3 2022 Nov 14, 2022	SELL	$5.72 - $7.76 $955 - $1,295	-167 Reduced 4.37%	3,656 $26,000
Q2 2022 Oct 27, 2022	BUY	$5.75 - $7.41 $5,422 - $6,987	943 Added 32.74%	3,823 $27,000
Q2 2022 Aug 15, 2022	BUY	$5.75 - $7.41 $5,422 - $6,987	943 Added 32.74%	3,823 $27,000
Q1 2022 Oct 27, 2022	SELL	$4.31 - $7.58 $4,064 - $7,147	-943 Reduced 24.67%	2,880 $17,000
Q1 2022 May 13, 2022	SELL	$4.31 - $7.58 $1,241 - $2,183	-288 Reduced 9.09%	2,880 $17,000
Q4 2021 Feb 14, 2022	SELL	$4.1 - $6.82 $15,817 - $26,311	-3,858 Reduced 54.91%	3,168 $20,000
Q3 2021 Nov 15, 2021	BUY	$6.75 - $9.52 $47,425 - $66,887	7,026 New	7,026 $49,000

9.06M

893K

Ticker AZYO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 9,308,720
Market Cap $13.5M
Description
Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo that combines the envelope with antibiotics and is designed to reduce the risk of inf...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.